---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-089781"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T19:57:31.323101+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Q3 revenue down to $2.9M; net loss widens to $3.1M; acquires Spindle Biotech

## Summary
- Revenue $2.9M vs $4.3M YoY; decline driven by COVID-19 testing drop and CUNY contract wind-down.
- Net loss $3.1M vs $1.1M YoY; operating loss flat at $2.9M; gross margin improved to 44%.
- Cash $10.8M at June 30, down from $12.3M at March 31; Adjusted EBITDA -$2.1M.
- Acquired Spindle Biotech post-quarter; launched Linea IVT platform for mRNA production.
- NYSDOH PGx diagnostic approval pending; added new CertainT customers for supply chain traceability.

## SEC filing metadata
- accession: 0001104659-23-089781
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465923089781/0001104659-23-089781-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465923089781/tm2323420d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-089781
- JSON: https://secwatch.observer/filing/0001104659-23-089781.json
- Plain text: https://secwatch.observer/filing/0001104659-23-089781.txt

## Key facts
- Earnings Releases
  BNB PLUS CORP. reported third quarter of fiscal 2023 ended June 30, 2023 results: revenue approximately $2.9 million, net income $3.1 million.
  - Period: third quarter of fiscal 2023 ended June 30, 2023
  - Revenue: approximately $2.9 million
  - Net income: $3.1 million
  - Result: reported results
  source text: potential for cotton taggant orders and the initiation of large supply chain customers.” Summary Third Quarter Fiscal 2023 Financial Results: · Total revenues were approximately $2.9 million for the three-month period June 30, 2023, compared to $4.3 million for the same period in the prior fiscal year. The decrease in revenue of approximately $1.4 million was due to
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465923089781/0001104659-23-089781-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.